Boult Wade Tennant
Service » Global plant breeders’ rights and national listings

We have a growing practice and specialist expertise in supporting major horticultural and biopharma clients in relation to plant breeders’ rights and national listings. The team is equipped to assist clients in national listings for plant varieties within the UK as well as obtaining rights across Europe. We also offer expert advice on the potential infringement risks associated with plant variety rights held by third parties.

 

What we do

Secure and preserve
  • We have significant experience in filing and prosecuting applications for plant breeders’ rights (known as plant variety rights in some countries) and national listings in the UK for our clients.
  • In this regard, we regularly act before the Plant Variety Rights Office of the UK Animal and Plant Health Agency (APHA) and have filed many applications using UPOV PRISMA.
  • We are regularly appointed as agent for existing UK plant breeders’ rights, particularly those created when the UK left the EU, and based upon former corresponding Community plant variety rights.
  • We are also able to coordinate the filing of plant variety right and national listing applications outside of the UK, including in the EU.

Technical toolkits

Services

image
Patents

Our European, UK and German experts advise on the creation, exploitation and enforcement of IP rights across a wide range of sectors. They provide creative IP solutions and outstanding client service.

MORE
image
Trade marks

Our highly skilled experts are experienced negotiators and have particular expertise in the management of large portfolios; searching and watching; domain name recovery; and trading standards and customs work.

MORE
image
Designs

The team can advise clients across a wide range of industries on matters of design law and practice. They combine their commercial knowledge with legal expertise to provide high quality advice that is always pragmatic.

MORE

Insights

image
IP updates
Injectable cancer immunotherapies: new innovations shortening treatment times and reducing costs

The NHS is introducing an injectable form of Keytruda (pembrolizumab), reducing administration time to under two minutes and helping improve patient experience.

image
IP updates
An appetiser before the main course of the G 1/25 decision on description amendments?

T 1043/24 aligns with the anticipated outcome of G 1/25, confirming that description amendments are needed to address inconsistencies with amended claims while allowing unclaimed embodiments to remain if clearly identified.

image
IP updates
Implementation of the EU Design regulation (Phase II)

From 1 July 2026, Phase II of the EU Design Reform introduces dynamic and animated representations, more design views, amendment options, and significant procedural changes.

image
IP updates
Happy 40th! Moldova becomes 40th EPC Contracting State

As of 1 June 2026, the Republic of Moldova officially became the 40th member state of the European Patent Organisation.

INSIGHTS

Patents